(Q54231363)

26 May 2018

title

Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients? (English)

1 reference

26 May 2018

author name string

McKee PJ

1

1 reference

26 May 2018

Blacklaw J

2

1 reference

26 May 2018

Friel E

3

1 reference

26 May 2018

Thompson GG

4

1 reference

26 May 2018

Gillham RA

5

1 reference

26 May 2018

Brodie MJ

6

1 reference

26 May 2018

publication date

1 September 1993

1 reference

26 May 2018

published in

Epilepsia

1 reference

26 May 2018

volume

34

1 reference

26 May 2018

issue

5

1 reference

26 May 2018

page(s)

937-943

1 reference

26 May 2018

Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Neuropathology of vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

The two-period cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

One to three day dose intervals during subchronic treatment of epileptic gerbils with gamma-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Effects of cimetidine on carbamazepine auto- and hetero-induction in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Response to vigabatrin in relation to seizure type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Clinical pharmacology of vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

Vigabatrin in complex partial seizures: a long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02115.X

10.1111/J.1528-1157.1993.TB02115.X

21 January 2018

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

8404750

1 reference

26 May 2018